In vitro and in vivo cancer cell apoptosis triggered by competitive binding of Cinchona alkaloids to the RING domain of TRAF6

被引:13
作者
Qi, Yonghao [1 ]
Zhao, Xuan [1 ]
Chen, Jiaying [1 ]
Pradipta, Ambara R. [2 ]
Wei, Jing [1 ]
Ruan, Haihua [3 ]
Zhou, Lijun [1 ]
Hsung, Richard P. [4 ]
Tanaka, Katsunori [2 ,4 ,5 ,6 ]
机构
[1] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin Key Lab Modern Drug Delivery & High Effic, Tianjin, Peoples R China
[2] RIKEN, Biofunct Synthet Chem Lab, Wako, Saitama, Japan
[3] Tianjin Univ Commerce, Tianjin, Peoples R China
[4] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 425 N Charter St, Madison, WI 53706 USA
[5] Kazan Fed Univ, A Butlerov Inst Chem, Biofunct Chem Lab, Kazan, Russia
[6] JST PRESTO, Wako, Saitama, Japan
关键词
Tumor; RING domain of TRAF6; Cinchona alkaloids; apoptosi; immune; NF-KAPPA-B; PROTEIN-KINASE; REGULATES BCL-2; ACTIVATION; TAK1; EXPRESSION; UBIQUITINATION; ALPHA; PROMOTES; GROWTH;
D O I
10.1080/09168451.2018.1559030
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
TRAF6 is highly expressed in many tumors and plays an important role in the immune system. The aim of this study is to confirm anti-tumor activities of all naturally occurring Cinchona alkaloids that have been screened using computational docking program, and to validate the accuracy and specificity of the RING domain of TRAF6 as a potential anti-tumor target, and to explore their effect on the immune system. Results reported herein would demonstrate that Cinchona alkaloids could induce apoptosis in HeLa cells, inhibit the ubiquitination and phosphorylation of both AKT and TAK1, and up-regulate the ratio of Bax/Bcl-2. In addition, these compounds could induce apoptosis in vivo, and increase the secretion of TNF-, IFN-, and IgG, while not significantly impacting the ratio of CD4(+)T/CD8(+)T. These investigations suggest that the RING domain of TRAF6 could serve as a de novo biological target for therapeutic treatment in cancers.
引用
收藏
页码:1011 / 1026
页数:16
相关论文
共 52 条
[1]   Ubiquitin-mediated activation of TAK1 and IKK [J].
Adhikari, A. ;
Xu, M. ;
Chen, Z. J. .
ONCOGENE, 2007, 26 (22) :3214-3226
[2]   Lyn kinase controls TLR4-dependent IKK and MAPK activation modulating the activity of TRAF-6/TAK-1 protein complex in mast cells [J].
Avila, Martin ;
Martinez-Juarez, Adriana ;
Ibarra-Sanchez, Alfredo ;
Gonzalez-Espinosa, Claudia .
INNATE IMMUNITY, 2012, 18 (04) :648-660
[3]   Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549) [J].
Bian, Hai-Bo ;
Pan, Xuan ;
Yang, Jin-Song ;
Wang, Zhao-Xia ;
De, Wei .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
[4]   Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity [J].
Carmi, Yaron ;
Spitzer, Matthew H. ;
Linde, Ian L. ;
Burt, Bryan M. ;
Prestwood, Tyler R. ;
Perlman, Nicola ;
Davidson, Matthew G. ;
Kenkel, Justin A. ;
Segal, Ehud ;
Pusapati, Ganesh V. ;
Bhattacharya, Nupur ;
Engleman, Edgar G. .
NATURE, 2015, 521 (7550) :99-U254
[5]   Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance [J].
Chatzigeorgioua, Antonios ;
Seijkens, Tom ;
Zarzycka, Barbara ;
Engel, David ;
Poggi, Marjorie ;
van den Berg, Susan ;
van den Berg, Sjoerd ;
Soehnlein, Oliver ;
Winkels, Holger ;
Beckers, Linda ;
Lievens, Dirk ;
Driessen, Ann ;
Kusters, Pascal ;
Biessen, Erik ;
Garcia-Martin, Ruben ;
Ameln, Anne Klotzsche-von ;
Gijbels, Marion ;
Noelle, Randolph ;
Boon, Louis ;
Hackeng, Tilman ;
Schulte, Klaus ;
Xu, Aimin ;
Vriend, Gert ;
Nabuurs, Sander ;
Chung, Kyoung-Jin ;
van Dijk, Ko Willems ;
Rensen, Patrick C. N. ;
Gerdes, Norbert ;
de Winther, Menno ;
Block, Norman L. ;
Schally, Andrew V. ;
Weber, Christian ;
Bornstein, Stefan R. ;
Nicolaes, Gerry ;
Chavakis, Triantafyllos ;
Lutgens, Esther .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (07) :2686-2691
[6]   TAK1 regulates NF-KB and AP-1 activation in airway epithelial cells following RSV infection [J].
Dey, Nilay ;
Liu, Tianshuang ;
Garofalo, Roberto P. ;
Casola, Antonella .
VIROLOGY, 2011, 418 (02) :93-101
[7]  
Diala I, 2013, ANAL SCI, V29, P927
[8]   The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis [J].
Engel, David ;
Seijkens, Tom ;
Poggi, Marjorie ;
Sanati, Maryam ;
Thevissen, Larissa ;
Beckers, Linda ;
Wijnands, Erwin ;
Lievens, Dirk ;
Lutgens, Esther .
SEMINARS IN IMMUNOLOGY, 2009, 21 (05) :308-312
[9]   Immune regulation by CD40 and its ligand GP39 [J].
Foy, TM ;
Aruffo, A ;
Bajorath, J ;
Buhlmann, JE ;
Noelle, RJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :591-617
[10]   Chrysin inhibits expression of hypoxia-inducible factor-1α through reducing hypoxia-inducible factor-1α stability and inhibiting its protein synthesis [J].
Fu, Beibei ;
Xue, Jing ;
Li, Zhaodong ;
Shi, Xianglin ;
Jiang, Bing-Hua ;
Fang, Jing .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) :220-226